These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23398399)

  • 1. The dynamic structure of α-synuclein multimers.
    Gurry T; Ullman O; Fisher CK; Perovic I; Pochapsky T; Stultz CM
    J Am Chem Soc; 2013 Mar; 135(10):3865-72. PubMed ID: 23398399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature?
    Binolfi A; Theillet FX; Selenko P
    Biochem Soc Trans; 2012 Oct; 40(5):950-4. PubMed ID: 22988846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct phases of free α-synuclein--a Monte Carlo study.
    Jónsson SA; Mohanty S; Irbäck A
    Proteins; 2012 Aug; 80(9):2169-77. PubMed ID: 22552968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explaining the structural plasticity of α-synuclein.
    Ullman O; Fisher CK; Stultz CM
    J Am Chem Soc; 2011 Dec; 133(48):19536-46. PubMed ID: 22029383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular crowding in the Escherichia coli periplasm maintains alpha-synuclein disorder.
    McNulty BC; Young GB; Pielak GJ
    J Mol Biol; 2006 Feb; 355(5):893-7. PubMed ID: 16343531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein as an intrinsically disordered monomer--fact or artefact?
    Coelho-Cerqueira E; Carmo-Gonçalves P; Pinheiro AS; Cortines J; Follmer C
    FEBS J; 2013 Oct; 280(19):4915-27. PubMed ID: 23927048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.
    Yamaguchi Y; Masuda M; Sasakawa H; Nonaka T; Hanashima S; Hisanaga S; Kato K; Hasegawa M
    J Mol Biol; 2010 Jan; 395(3):445-56. PubMed ID: 19895818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation.
    Bertoncini CW; Rasia RM; Lamberto GR; Binolfi A; Zweckstetter M; Griesinger C; Fernandez CO
    J Mol Biol; 2007 Sep; 372(3):708-22. PubMed ID: 17681539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations.
    Dedmon MM; Lindorff-Larsen K; Christodoulou J; Vendruscolo M; Dobson CM
    J Am Chem Soc; 2005 Jan; 127(2):476-7. PubMed ID: 15643843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the ubiquity of helical α-synuclein tetramers.
    Xu L; Bhattacharya S; Thompson D
    Phys Chem Chem Phys; 2019 Jun; 21(22):12036-12043. PubMed ID: 31135803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yet another polymorph of α-synuclein: solid-state sequential assignments.
    Gath J; Bousset L; Habenstein B; Melki R; Meier BH; Böckmann A
    Biomol NMR Assign; 2014 Oct; 8(2):395-404. PubMed ID: 24114178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-bound structure and energetics of alpha-synuclein.
    Mihajlovic M; Lazaridis T
    Proteins; 2008 Feb; 70(3):761-78. PubMed ID: 17729279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
    J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-cell NMR characterization of the secondary structure populations of a disordered conformation of α-synuclein within E. coli cells.
    Waudby CA; Camilloni C; Fitzpatrick AW; Cabrita LD; Dobson CM; Vendruscolo M; Christodoulou J
    PLoS One; 2013; 8(8):e72286. PubMed ID: 23991082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helical alpha-synuclein forms highly conductive ion channels.
    Zakharov SD; Hulleman JD; Dutseva EA; Antonenko YN; Rochet JC; Cramer WA
    Biochemistry; 2007 Dec; 46(50):14369-79. PubMed ID: 18031063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UV-induced selective oxidation of Met5 to Met-sulfoxide leads to the formation of neurotoxic fibril-incompetent α-synuclein oligomers.
    Carmo-Gonçalves P; Pinheiro AS; Romão L; Cortines J; Follmer C
    Amyloid; 2014 Sep; 21(3):163-74. PubMed ID: 24784227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.
    Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE
    J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray Crystallographic Structure of Oligomers Formed by a Toxic β-Hairpin Derived from α-Synuclein: Trimers and Higher-Order Oligomers.
    Salveson PJ; Spencer RK; Nowick JS
    J Am Chem Soc; 2016 Apr; 138(13):4458-67. PubMed ID: 26926877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural properties of pore-forming oligomers of alpha-synuclein.
    Kim HY; Cho MK; Kumar A; Maier E; Siebenhaar C; Becker S; Fernandez CO; Lashuel HA; Benz R; Lange A; Zweckstetter M
    J Am Chem Soc; 2009 Dec; 131(47):17482-9. PubMed ID: 19888725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.